Neolpharma, a Mexican pharmaceutical group specializing in the production of generic medicines and contract manufacturing, opened operations yesterday in Caguas in a plant that used to be owned by Pfizer. The company might be a new business model for Puerto Rico, for the research and development market of "differentiated generics", a type of off-patent medicines that are more technically challenging to produce than regular generics. Neolpharma relocated to Puerto Rico, despite higher production costs, because of the talent pool of potential workers.
The original news story is in Spanish. To read the full text, please click on the "Español" button below or the link at the top right of the page.